1-13 of 13
Erin Mulvey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SGR-1505, a potent and selective MALT1 inhibitor with preliminary efficacy in BTKi exposed Waldenström macroglobulinemia (WM) and “double-exposed” CLL/SLL

Free
Stephen Spurgeon, Vincent Ribrag, Vasile Musteata, Oksana Karnabeda, Mengyang Di, Nashat Gabrail, Guru Subramanian Guru Murthy, Laura Calustian, Erin Mulvey, Michal Taszner, Sen Zhang, Wu Yin, Min Ye, Frank Basile, Netonia Marshall, Wenxin Zheng, Brian Yoo, Allison Upalawanna, Margaret Dugan, Karen Akinsanya, Matthew Ulrickson, Ciprian Tomuleasa, Carlo Visco, Adam Olszewski
Journal: Blood
Blood (2025) 146 (Supplement 1): 3603.
https://doi.org/10.1182/blood-2025-3603
Published: 2025
Journal Articles

Zanubrutinib and venetoclax as initial therapy for CLL/SLL with obinutuzumab triplet consolidation in patients with detectable minimal residual disease (BruVenG).

Free
John Allan, Erin Mulvey, Daniel Helbig, Nikita Malakhov, Zhengming Chen, Brittany Hobbie, Sarah Nazir, Jerrod White, Zahra Grant, Jane Matejka, Simone Morris, Liming Bao, Peter Martin, Richard Furman
Journal: Blood
Blood (2025) 146 (Supplement 1): 3886.
https://doi.org/10.1182/blood-2025-3886
Published: 2025
Journal Articles

Access to acute promyelocytic leukemia treatment in New York City

Free
James Yoon, Maher Abdul Hay, Marina Konopleva, Roy Browne, Sonjela Bulku, Jonathan Canaani, Victoria Forte, Nelli Fromer, Vladimir Gotlieb, Joseph Jurcic, John Mascarenhas, Anne Monarch, Erin Mulvey, Rosa Nouvini, Orrin Pail, Nelly Pakh, Samantha Paone, Vincent Rizzo, Salom Suh, Alina Varabyeva, Vernon Wu, Eytan Stein
Journal: Blood
Blood (2025) 146 (Supplement 1): 6205.
https://doi.org/10.1182/blood-2025-6205
Published: 2025
Journal Articles

Effectiveness of epcoritamab in a heterogeneous population with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) including post-chimeric antigen receptor T-cell therapy (CAR T) patients: Insights from the real-world epcoritamab patient characteristics and outcomes research (Real-EPCOR) study

Free
Amir Ali, Pallawi Torka, Yucai Wang, Tara Graff, Erin Mulvey, Yumeng Zhang, Monika Jun, Abualbishr Alshreef, Alex Mutebi, Anthony Wang, David Tybor, Lynn Huynh, Angela Lax, Tychell Branchcomb, Mei Sheng Duh, Javier Munoz, Muhamad Alhaj Moustafa, Nausheen Ahmed
Journal: Blood
Blood (2025) 146 (Supplement 1): 8075.
https://doi.org/10.1182/blood-2025-8075
Published: 2025
Journal Articles

The future of follicular lymphoma management: strategies on the horizon

Available to Purchase
Erin Mulvey, Sarah C. Rutherford, John P. Leonard
Journal: Blood
Blood (2025) 146 (15): 1792–1801.
https://doi.org/10.1182/blood.2024026017
Published: 2025
Journal Articles

The Predictive Value of Cell-of-Origin Subtype By Hans Algorithm in 718 Patients with Large B Cell Lymphoma Receiving Polatuzumab Vedotin

Free
Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan, Varun Iyengar, Jihao Zhou, Kevin Chung, Nayef Abdel-Razeq, Ajay Major, Jessica M Allen, John Sharp, Narendranath Epperla, Patrick Gould, Hua-Jay J Cherng, Samin Houshyar, Danielle S Wallace, Ryan C. Lynch, Avyakta Kallam, Matthew Mei, Reid W. Merryman, Michelle Fleyshman, Joanna M. Rhodes, Adam Kidwell, Timothy S Fenske, Erin Mulvey, Marcus P. Watkins, Muhamad Alhaj Moustafa, Talal Hilal, Grzegorz S. Nowakowski, Yucai Wang, Pallawi Torka, David A Russler-Germain
Journal: Blood
Blood (2024) 144 (Supplement 1): 652.
https://doi.org/10.1182/blood-2024-202153
Published: 2024
Journal Articles

Enhancing Diagnostic and Prognostic Strategies in Secondary HLH: Insights from the Weill-Cornell Medicine Experience

Free
Justin D. Kaner, Danny Luan, Franco Castillo Tokumori, John-William Sidhom, Jose Fernandez-Rengifo, Samantha Gerson, Matthew Whitcomb, Molly Vallon, Ellen K. Ritchie, Michael Samuel, Jonathan Canaani, Michal Bar-Natan, Erin Mulvey, Peter Martin, Pinkal Desai, John N. Allan, Richard R. Furman, Sarah C. Rutherford, Jia Ruan, Gail J. Roboz
Journal: Blood
Blood (2024) 144 (Supplement 1): 5379.
https://doi.org/10.1182/blood-2024-210134
Published: 2024
Journal Articles

Zanubrutinib and Venetoclax As Initial Therapy for CLL/SLL with Obinutuzumab Triplet Consolidation in Patients with Minimal Residual Disease Positivity (BruVenG)

Free
John N. Allan, Daniel Helbig, Erin Mulvey, Sarah Nazir, Sandra Stewart, Melissa L. Lapinta, Sarah C. Rutherford, Jia Ruan, John P. Leonard, Peter Martin, Richard R. Furman
Journal: Blood
Blood (2023) 142 (Supplement 1): 3285.
https://doi.org/10.1182/blood-2023-174465
Published: 2023
Journal Articles

Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL

Free
Clinical Trials & Observations
Jia Ruan, Alison Moskowitz, Neha Mehta-Shah, Lubomir Sokol, Zhengming Chen, Nikita Kotlov, Grigorii Nos, Maria Sorokina, Vladislav Maksimov, Andrea Sboner, Michael Sigouros, Koen van Besien, Steven Horwitz, Sarah C. Rutherford, Erin Mulvey, Maria V. Revuelta, Jenny Xiang, Alicia Alonso, Ari Melnick, Olivier Elemento, Giorgio Inghirami, John P. Leonard, Leandro Cerchietti, Peter Martin
Journal: Blood
Blood (2023) 141 (18): 2194–2205.
https://doi.org/10.1182/blood.2022018254
Published: 2023
Includes: Supplemental data
Journal Articles

Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL

Open Access
Clinical Trials & Observations
Peter Martin, Nancy L. Bartlett, Julio C. Chavez, John L. Reagan, Sonali M. Smith, Ann S. LaCasce, Jeffrey Jones, James Drew, Chengqing Wu, Erin Mulvey, Maria V. Revuelta, Leandro Cerchietti, John P. Leonard
Journal: Blood
Blood (2022) 139 (8): 1147–1159.
https://doi.org/10.1182/blood.2021011679
Published: 2022
Includes: Supplemental data
Journal Articles

Overexpression of Deleted Lymphocytic Leukemia 1 (DLEU1) Inhibits Proliferation of Burkitt Lymphoma (BL).

Free
Sanghoon Lee, PhD, MSc, Changhong Yin, MS, Janet Ayello, MS, MT(ASCP), Carmella van de Ven, MA, Charles Biggar, Henry Kwang, BA, Erin Mulvey, BA, James Pao, BA, Mitchell S. Cairo, MD
Journal: Blood
Blood (2012) 120 (21): 2654.
https://doi.org/10.1182/blood.V120.21.2654.2654
Published: 2012
Journal Articles

Talens-Mediated DLEU1 Gene Silencing in Burkitt Lymphoma (BL): Implication of Lncrna DLEU1 Gene As a Potential Tumor Suppressor Gene in BL.

Free
Sanghoon Lee, PhD, MSc, Changhong Yin, MS, Janet Ayello, MS, MT(ASCP), Carmella van de Ven, MA, Henry Hwang, BA, Charles Biggar, James Pao, BA, Erin Mulvey, BA, Mitchell S. Cairo, MD
Journal: Blood
Blood (2012) 120 (21): 2403.
https://doi.org/10.1182/blood.V120.21.2403.2403
Published: 2012
Journal Articles

JAK1/JAK2 Inhibitor, Ruxolitinib Inhibits Cell Proliferation and Induces Apoptosis in Hodgkin Lymphomas (HL) and Primary Mediastinal B-Cell Lymphomas (PMBL)

Free
Changhong Yin, MS, Sanghoon Lee, PhD, MSc, Janet Ayello, MS, MT(ASCP), Carmella van de Ven, MA, James Pao, BA, Erin Mulvey, BA, Mitchell S. Cairo, MD
Journal: Blood
Blood (2012) 120 (21): 4886.
https://doi.org/10.1182/blood.V120.21.4886.4886
Published: 2012